Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

2.02
-0.0300-1.47%
Volume:522.67K
Turnover:1.07M
Market Cap:290.08M
PE:-1.92
High:2.12
Open:2.03
Low:2.01
Close:2.05
Loading ...

Maravai LifeSciences Q1 Revenue USD 56.6 Million VS. Ibes Estimate USD 44.1 Million

THOMSON REUTERS
·
18 Apr

RBC Capital Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
03 Apr

Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
26 Mar

Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?

Insider Monkey
·
26 Mar

Maravai LifeSciences Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
25 Mar

RBC Capital Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
25 Mar

Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
22 Mar

Maravai LifeSciences Is Maintained at Neutral by UBS

Dow Jones
·
21 Mar

Strategic Acquisitions and Market Expansion Drive Buy Rating for Maravai Lifesciences Holdings

TIPRANKS
·
21 Mar

Deutsche Bank Adjusts Price Target on Maravai Lifesciences to $5 From $10, Keeps Buy Rating

MT Newswires Live
·
21 Mar

Maravai LifeSciences Holdings Inc : RBC Cuts Target Price to $7 From $11

THOMSON REUTERS
·
21 Mar

BRIEF-Maravai Lifesciences Holdings Inc Outlook 2025 Revenue $185.0 Million To $205.0 Million

Reuters
·
21 Mar

Maravai LifeSciences Holdings Inc Outlook Q1 $43.0 Million to $45.0 Million

THOMSON REUTERS
·
21 Mar

Maravai LifeSciences Holdings Inc FY2025 REV View $263.8 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
21 Mar

Craig-Hallum Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
19 Mar

Buy Rating for Maravai Lifesciences Holdings: Strategic Financial Decisions and Growth Potential Amidst Challenges

TIPRANKS
·
19 Mar

Maravai Lifesciences Q4 Swings to Adjusted Loss, Revenue Declines

MT Newswires Live
·
19 Mar

Maravai LifeSciences Q4 Revenue USD 56.6 Million VS. Ibes Estimate USD 57.3 Million

THOMSON REUTERS
·
19 Mar

Press Release: Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
19 Mar

Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
15 Mar